Long noncoding RNA TUG1 decreases bladder cancer chemo-sensitivity toward doxorubicin through elevating KPNA2 expression and activating the PI3K/AKT pathway via adsorbing miR-582-5p-Reference-Cited by-同舟云学术

Long noncoding RNA TUG1 decreases bladder cancer chemo-sensitivity toward doxorubicin through elevating KPNA2 expression and activating the PI3K/AKT pathway via adsorbing miR-582-5p

Published:2022-10-16 Issue:1 Volume:34 Page:144-154
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Lu Peng,Jiang Yingchun,Xia Zongyu

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference34 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.;Bray;CA Cancer J Clin,2018

2. Chemotherapy for muscle-invasive bladder cancer.;Trenta;Curr Treat Options Oncol,2016

3. Derlin-1 overexpression confers poor prognosis in muscle invasive bladder cancer and contributes to chemoresistance and invasion through PI3K/AKT and ERK/MMP signaling.;Dong;Oncotarget,2017

4. Long non-coding RNA: a new player in cancer.;Zhang;J Hematol Oncol,2013

5. Long noncoding RNAs as biotargets in cisplatin-based drug resistance.;Abu;Future Oncol,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Critical roles of lncRNA-mediated autophagy in urologic malignancies;Frontiers in Pharmacology;2024-06-13

2. DoxoDB: A Database for the Expression Analysis of Doxorubicin-Induced lncRNA Genes;Non-Coding RNA;2023-07-13

3. Regulatory miRNAs in cancer cell recovery from therapy exposure and its implications as a novel therapeutic strategy for preventing disease recurrence;The Enzymes;2023